Sugi Predict

Sugi Predict / Compounds / SCHEMBL10127741

SCHEMBL10127741

SCHEMBL10127741

CCC(C)c1ccc2c(c1)c1cc(C(C)CC)ccc1n2-c1ccc(-c2nnc3c4ccccc4c4ccccc4n23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ TP53 P04637 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ RORA P35398 1/20 0.34
▸ RORC P51449 1/20 0.34
▸ RORB Q92753 1/20 0.34
▸ UCHL3 P15374 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PTGER4 P35408 1/20 0.32
▸ PDE2A O00408 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ HPGD P15428 1/20 0.32
▸ PTPN1 P18031 1/20 0.32
▸ AKR1C4 P17516 1/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ AKR1C1 Q04828 1/20 0.32
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10127805 1.00 POLB (0.41) POLBRXFP1TP53MAPTRORA
SCHEMBL10127806 0.89 POLB (0.44) POLBRXFP1TP53MAPTRORA
SCHEMBL10127732 0.89 POLB (0.44) POLBRXFP1TP53MAPTRORA
SCHEMBL10128673 0.86 POLB (0.39) POLBRXFP1TP53MAPTRORA
SCHEMBL10128488 0.86 POLB (0.39) POLBRXFP1TP53MAPTRORA
SCHEMBL17570253 0.83 RXFP1 (0.43) RXFP1MAPTRORARORCRORB
SCHEMBL12110608 0.83 RXFP1 (0.43) RXFP1MAPTRORARORCRORB
SCHEMBL10127794 0.83 POLB (0.47) POLBTP53MAPTRORARORC
SCHEMBL10127725 0.83 POLB (0.47) POLBTP53MAPTRORARORC
SCHEMBL10127717 0.82 POLB (0.47) POLBRXFP1TP53MAPTRORA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 — — US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 — — US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 — — US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 POLB 3317/4885RXFP1 3981/4885TP53 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.